These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9209657

  • 1. Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice.
    Lacerda JF, O'Reilly RJ.
    Ann Oncol; 1997; 8 Suppl 2():137-40. PubMed ID: 9209657
    [Abstract] [Full Text] [Related]

  • 2. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

  • 3. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
    Khatri VP, Baiocchi RA, Peng R, Oberkircher AR, Dolce JM, Ward PM, Herzig GP, Caligiuri MA.
    J Immunol; 1999 Jul 01; 163(1):500-6. PubMed ID: 10384154
    [Abstract] [Full Text] [Related]

  • 4. Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation.
    Hoffmann T, Russell C, Vindelov L.
    APMIS; 2002 Feb 01; 110(2):148-57. PubMed ID: 12064870
    [Abstract] [Full Text] [Related]

  • 5. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL.
    J Immunol; 2000 Jul 01; 165(1):518-27. PubMed ID: 10861091
    [Abstract] [Full Text] [Related]

  • 6. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 01; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
    Johannessen I, Bieleski L, Urquhart G, Watson SL, Wingate P, Haque T, Crawford DH.
    J Med Virol; 2011 Sep 01; 83(9):1585-96. PubMed ID: 21739450
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
    Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M.
    Bone Marrow Transplant; 2001 Jan 01; 27(1):53-64. PubMed ID: 11244438
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
    Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG.
    Blood; 2000 Feb 01; 95(3):807-14. PubMed ID: 10648390
    [Abstract] [Full Text] [Related]

  • 10. Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients.
    Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, Brenner MK, Heslop HE, Rooney CM.
    Transplantation; 2001 Sep 27; 72(6):1078-86. PubMed ID: 11579304
    [Abstract] [Full Text] [Related]

  • 11. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.
    J Clin Oncol; 2005 Dec 10; 23(35):8942-9. PubMed ID: 16204009
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
    Wheatley GH, McKinnon KP, Iacobucci M, Mahon S, Gelber C, Lyerly HK.
    Surgery; 1998 Aug 10; 124(2):171-6. PubMed ID: 9706135
    [Abstract] [Full Text] [Related]

  • 13. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.
    Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, Gee AP, Brenner MK, Heslop HE, Rooney CM.
    Blood; 2002 Dec 01; 100(12):4059-66. PubMed ID: 12393655
    [Abstract] [Full Text] [Related]

  • 14. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul 01; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ex vivo priming of naïve T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL.
    Popescu I, Macedo C, Zeevi A, Nellis J, Patterson KR, Logar A, Rowe D, Reyes J, Rao AS, Storkus WJ, Fung JJ, Metes D.
    Am J Transplant; 2003 Nov 01; 3(11):1369-77. PubMed ID: 14525597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
    Swinnen LJ.
    Best Pract Res Clin Haematol; 2006 Nov 01; 19(4):839-47. PubMed ID: 16997187
    [Abstract] [Full Text] [Related]

  • 20. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.